BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37881743)

  • 1. A Simplified Risk Score to Estimate the Risk of Contrast-Induced Nephropathy after Contrast Exposure.
    Kulkarni CS; Kothari JP; Sirsat RA; Almeida AF
    Indian J Nephrol; 2023; 33(5):333-339. PubMed ID: 37881743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple risk score model for predicting contrast-induced nephropathy after coronary angiography in patients with diabetes.
    Zeng JF; Chen SQ; Ye JF; Chen Y; Lei L; Liu XQ; Liu Y; Wang Y; Lin JJ; Chen JY
    Clin Exp Nephrol; 2019 Jul; 23(7):969-981. PubMed ID: 31049747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel risk assessment model of contrast-induced nephropathy after percutaneous coronary intervention in patients with diabetes.
    Yao ZF; Shen H; Tang MN; Yan Y; Ge JB
    Basic Clin Pharmacol Toxicol; 2021 Feb; 128(2):305-314. PubMed ID: 32991776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation and validation of a risk score for contrast-induced nephropathy after cardiac catheterization in Chinese patients.
    Gao YM; Li D; Cheng H; Chen YP
    Clin Exp Nephrol; 2014 Dec; 18(6):892-8. PubMed ID: 24515307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel risk score of contrast-induced nephropathy after percutaneous coronary intervention.
    Ji L; Su X; Qin W; Mi X; Liu F; Tang X; Li Z; Yang L
    Nephrology (Carlton); 2015 Aug; 20(8):544-51. PubMed ID: 25706048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention.
    Maioli M; Toso A; Gallopin M; Leoncini M; Tedeschi D; Micheletti C; Bellandi F
    J Cardiovasc Med (Hagerstown); 2010 Jun; 11(6):444-9. PubMed ID: 20164783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel risk score model for prediction of contrast-induced nephropathy after emergent percutaneous coronary intervention.
    Lin KY; Zheng WP; Bei WJ; Chen SQ; Islam SM; Liu Y; Xue L; Tan N; Chen JY
    Int J Cardiol; 2017 Mar; 230():402-412. PubMed ID: 28043662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors and scoring system in the prediction of contrast induced nephropathy in patients undergoing percutaneous coronary intervention].
    Fu NK; Yang SC; Chen YL; Xu J; Li Q; Li XM; Liu YY; Liu XG; Cong HL
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(8):551-4. PubMed ID: 22490160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.
    Mehran R; Aymong ED; Nikolsky E; Lasic Z; Iakovou I; Fahy M; Mintz GS; Lansky AJ; Moses JW; Stone GW; Leon MB; Dangas G
    J Am Coll Cardiol; 2004 Oct; 44(7):1393-9. PubMed ID: 15464318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-induced nephropathy after peripheral vascular intervention: Long-term renal outcome and risk factors for progressive renal dysfunction.
    Al Adas Z; Lodewyk K; Robinson D; Qureshi S; Kabbani LS; Sullivan B; Shepard AD; Weaver MR; Nypaver TJ
    J Vasc Surg; 2019 Mar; 69(3):913-920. PubMed ID: 30292616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of contrast volume/glomerular filtration rate ratio in contrast-induced nephropathy patients after transcatheter aortic valve implantation.
    Gul I; Zungur M; Tastan A; Okur FF; Damar E; Uyar S; Sahin V; Tavli T
    Cardiorenal Med; 2015 Feb; 5(1):31-9. PubMed ID: 25759698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Prediction for Contrast-Induced Nephropathy in Cancer Patients Undergoing Computed Tomography under Preventive Measures.
    Jeon J; Kim S; Yoo H; Kim K; Kim Y; Park S; Jang HR; Kim DK; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Oncol; 2019; 2019():8736163. PubMed ID: 31057617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical Risk Stratification Score for Prediction of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention in Patients With Acute ST-Segment Elevation Myocardial Infarction.
    Koowattanatianchai S; Chantadansuwan T; Kaladee A; Phinyo P; Patumanond J
    Cardiol Res; 2019 Dec; 10(6):350-357. PubMed ID: 31803333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of PRECISE-DAPT score with development of contrast-induced nephropathy in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Çınar T; Tanık VO; Aruğaslan E; Karabağ Y; Çağdaş M; Rencüzoğulları İ; Keskin M
    Cardiovasc Interv Ther; 2019 Jul; 34(3):207-215. PubMed ID: 30191494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a new risk score to predict contrast-induced nephropathy after percutaneous coronary intervention.
    Tziakas D; Chalikias G; Stakos D; Altun A; Sivri N; Yetkin E; Gur M; Stankovic G; Mehmedbegovic Z; Voudris V; Chatzikyriakou S; Garcia-Moll X; Serra A; Passadakis P; Thodis E; Vargemezis V; Kaski JC; Konstantinides S
    Am J Cardiol; 2014 May; 113(9):1487-93. PubMed ID: 24630389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice.
    Tziakas D; Chalikias G; Stakos D; Apostolakis S; Adina T; Kikas P; Alexoudis A; Passadakis P; Thodis E; Vargemezis V; Konstantinides S
    Int J Cardiol; 2013 Feb; 163(1):46-55. PubMed ID: 21641061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Predictive Model Based on a New CI-AKI Definition to Predict Contrast Induced Nephropathy in Patients With Coronary Artery Disease With Relatively Normal Renal Function.
    Mo H; Ye F; Chen D; Wang Q; Liu R; Zhang P; Xu Y; Cheng X; Mei Z; Zheng Y; Dai Y; Jiang S; Ge J
    Front Cardiovasc Med; 2021; 8():762576. PubMed ID: 34778413
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictive Value of the Mehran Score for Contrast-Induced Nephropathy after Transcatheter Aortic Valve Implantation in Patients with Aortic Stenosis.
    Zungur M; Gul I; Tastan A; Damar E; Tavli T
    Cardiorenal Med; 2016 Aug; 6(4):279-88. PubMed ID: 27648009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of C-Reactive Protein as a Predictor of Contrast-Induced Nephropathy After Percutaneous Coronary Interventions in Patients With Acute Myocardial Infarction and Presentation of a New Risk Score (Athens CIN Score).
    Lazaros G; Zografos T; Oikonomou E; Siasos G; Georgiopoulos G; Vavuranakis M; Antonopoulos A; Kalogeras K; Tsalamandris S; Tousoulis D
    Am J Cardiol; 2016 Nov; 118(9):1329-1333. PubMed ID: 27745963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of the Logistic Clinical Syntax Score in the Prediction of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.
    Ozturk D; Celik O; Erturk M; Kalkan AK; Uzun F; Akturk IF; Akin F; Yildirim A
    Can J Cardiol; 2016 Feb; 32(2):240-6. PubMed ID: 26255218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.